Preparation method of giant liposome without dehumidification of surfactant
Through microfluidic technology without surfactants, phospholipids, trioleate glyceride, polyvinyl alcohol or sucrose aqueous solution are used to form a water-in-oil dual emulsion, and spontaneously dehumidify the preparation of giant liposomes, solving the uneven size in the existing methods and biocompatibility issues, achieving high envelope rate and stability.
Patent Information
- Application Number
- CN202411144525.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-26
AI Technical Summary
The existing giant liposome preparation methods have problems such as uneven size, difficulty in controlling and low packaging efficiency of loaded substances. The adhesion of surfactant affects biophysical characteristics and stability, and the residual organic solvent is toxic to the biologically active ingredients.
Using microfluidic technology without surfactant, the first dispersed phase fluid is formed by mixing phospholipids and glyceryl trioleate, combined with polyvinyl alcohol or sucrose aqueous solution to form a continuous phase, forming a water-in-oil double emulsion and spontaneously dehumidify, using phospholipids The versatile self-assembly forms a stable oil-water interface, realizing the preparation of giant liposomes.
Achieve monodispersed, uniform size, adjustable size, uniform encapsulation, high encapsulation rate and biocompatibility of giant liposomes, avoiding the use of surfactants, and improving the stability and biosafety of liposomes .
Smart Images

Figure CN119015993A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to a method for preparing giant liposomes without surfactant dehumidification, and belongs to the technical field of microcapsule or microsphere manufacturing in colloid chemistry. Background Art
[0002] Liposomes are a type of molecular ordered assembly with a closed bilayer structure that is self-assembled from phospholipid molecules. They are also called phospholipid vesicles, which have a water core surrounded by one or more phospholipid bilayers or lamellae. Liposomes can be classified according to their size (small, large and giant liposomes), the number of phospholipid layers (monolayer, oligolayer and multilayer) and the charge of phospholipids (neutral, anionic or cationic). Giant liposomes (GUVs) are liposomes with a particle size greater than 1μm, ultra-high encapsulation volume and encapsulation rate, and a size close to that of most biological cells. They are widely used as artificial cell models, drug carriers and reaction primitives. Therefore, GUVs have potential application value in many fields such as analytical testing, biomedicine, chemistry, and materials.
[0003] GUVs are mainly prepared by traditional methods such as hydration, electroformation, and phase transfer, which have disadvantages such as uneven size, difficulty in control, and low encapsulation efficiency of loaded substances. All of the above disadvantages can be overcome by using microfluidic technology to prepare lipid-based vesicles, giving GUVs obtained by microfluidic technology the advantages of monodispersity, adjustable size, high encapsulation rate, and uniform encapsulation. The microfluidic method prepares water-in-oil-in-water (W / O / W) double emulsions, phospholipids are dissolved in the intermediate oil phase, surfactants are added to the continuous phase fluid to complete the dewetting process, and the organic layer is removed by the dewetting process to obtain giant liposomes. Double emulsions can easily incorporate hydrophilic and hydrophobic drugs into liposomes, and are also used to encapsulate proteins, nucleic acids, cells, and microparticles into liposomes.
[0004] However, the attachment of surfactants to the surface of liposomes not only changes the biophysical properties of the membrane, but also has an adverse effect on studies such as the assembly of proteins on the membrane. The liposomes ultimately formed using the double emulsion method will also have residual organic solvents, which may be highly toxic to biologically active ingredients, which is not conducive to research in bionic fields such as artificial cells, and may reduce the stability of the liposomes. Summary of the invention
[0005] In view of this, the present application provides a method for preparing giant liposomes without surfactant dehumidification. The entire preparation process does not require the addition of surfactants. The finished liposomes have good biocompatibility and can be applied to artificial cells and biological fields.
[0006] Specifically, the present application is implemented through the following scheme: A method for preparing giant liposomes without surfactant dewetting, wherein phospholipids and triolein are mixed to form a first dispersed phase fluid, a continuous phase fluid is used as an external phase, the first dispersed phase fluid is used as an intermediate phase, and a second dispersed phase fluid is used as an internal phase. The three are respectively injected into a microfluidic device, and the formed double emulsion is spontaneously dewetted to obtain giant liposomes with an external diameter of 30 to 150 μm.
[0007] In the above scheme, the lipid-containing first dispersed phase fluid (oil phase, LO) shears the second dispersed phase fluid (inner aqueous phase, IA) to form a single emulsion of oil-in-water (W / O), and the single emulsion is further sheared by the external continuous phase fluid (outer aqueous phase, OA) to form a double emulsion (W / O / W). The amphiphilicity of phospholipids enables them to self-assemble at the two oil-water interfaces of the double emulsion to form a phospholipid molecular layer that stabilizes the oil-water interface. The above composition gives the structure a spontaneous dewetting property and can continuously produce a monodisperse emulsion, and the phospholipid bilayer formed during the dewetting process is the liposome. During the molding process, the size of the internal phase droplets determines the size of the liposome. In this case, the first dispersed phase fluid cooperates with the continuous phase and the second dispersed phase fluid and the molding process of the microfluidic device to achieve osmotic pressure balance in the molding process, stable liposome molding, uniform size, and adjustable size.
[0008] Further, as a preference: The continuous phase fluid is a polyvinyl alcohol aqueous solution or a sucrose aqueous solution, and the continuous phase satisfies a certain viscosity, which causes the single emulsion to form a double emulsion when the shearing effect is exerted. More preferably, the sucrose aqueous solution is a mixture of sucrose and deionized water, and the mass ratio of sucrose to deionized water is 0.05 to 0.1:1. The polyvinyl alcohol aqueous solution is a mixture of polyvinyl alcohol and deionized water, and the mass ratio of polyvinyl alcohol to water is 0.01 to 0.3:1. Add polyvinyl alcohol to deionized water at normal pressure and room temperature, and stir evenly to form a continuous phase fluid.
[0009] In the first dispersed phase fluid, the amount of phospholipids in each mL of triolein is 0.001-0.02 g. More preferably, the preparation method of the first dispersed phase fluid is: at normal pressure and room temperature, a chloroform solution of phospholipids is blown dry with nitrogen to form a phospholipid film, triolein is added, and the phospholipids are ultrasonically dissolved at 50° C. to form the first dispersed phase fluid.
[0010] The second dispersed phase fluid is a polyethylene glycol aqueous solution, an aqueous solution of polyvinyl alcohol and polyethylene glycol, or a glucose aqueous solution. More preferably, in the polyethylene glycol aqueous solution, the mixing mass ratio of polyethylene glycol to deionized water is 0.01-0.3:1; in the glucose aqueous solution, the mass ratio of glucose to deionized water is 0.01-0.1:1. The mass ratios of polyvinyl alcohol to deionized water and polyethylene glycol to deionized water are 0.01-0.1:1 and 0.01-0.3:1, respectively. Polyethylene glycol and polyvinyl alcohol are added to deionized water at normal pressure and room temperature, and stirred evenly to form a second dispersed phase. The above solution maintains a balance with the continuous phase osmotic pressure, which can prevent the rupture of liposomes and effectively achieve the stability of liposomes.
[0011] In the microfluidic device, the flow rate Q of the first dispersed phase fluid is O The flow rate of the second dispersed phase fluid Q is 50~1000μL / h. W1 The flow rate of the continuous phase fluid is 50 to 1000 μL / h. W2 The flow rate is 1000-5000 μL / h. During the preparation process, the uniformity and adjustable size of the liposomes can be achieved with the aid of a microfluidic device.
[0012] The microfluidic device is a PDMS microfluidic device, with three liquid inlets, three corresponding syringes fixed thereto, and one liquid outlet.
[0013] The present invention has the following beneficial effects: First, the preparation method of the present invention is simple to operate, easy to control and adjust, and can continuously produce monodisperse, high encapsulation efficiency, surfactant-free, biomolecule-compatible giant liposome vesicles.
[0014] Second, the preparation method of the present invention can accurately control the components and content of the vesicle contents, and the method can be used for research in the fields of drug transport, release and artificial cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 is a schematic diagram of the structure of the microfluidic device in this application, Numbers in the figure: 1. Liquid inlet 1, 2. Liquid inlet 2, 3. Liquid inlet 3, 4. Liquid outlet; Figure 2 It is a camera picture of double emulsion dehumidification to form liposomes; Figure 3 It is a camera photo of the double emulsion dehumidification process; Figure 4 This is a fluorescence microscopy photograph of liposomes. DETAILED DESCRIPTION
[0016] The preparation method of giant liposomes without surfactant of the present invention is further described below by examples and in conjunction with the accompanying drawings, but the present invention is not limited to these examples.
[0017] The preparation in this embodiment mainly includes:
[0018] The molecular weight of polyvinyl alcohol is 13000-23000 and is purchased from Sigma-Aldrich Company.
[0019] Polyethylene glycol with a molecular weight of 6000 was purchased from Sigma-Aldrich.
[0020] Triolein was purchased from Sinopharm.
[0021] Phospholipids were purchased from Avanti.
[0022] The equipment of this embodiment mainly includes:
[0023] The following embodiments can use various types of microfluidic devices with double emulsion generators, taking the PDMS microfluidic device as an example, combined with Figure 1 , which includes three liquid inlets: liquid inlet 1, liquid inlet 2, liquid inlet 3 and a liquid outlet 4. Each liquid inlet corresponds to an injection tube (not shown in the figure), which is fixed at the corresponding liquid inlet. The continuous phase fluid is injected into the liquid inlet 1, the first dispersed phase fluid is injected into the liquid inlet 2, and the second dispersed phase fluid is injected into the liquid inlet 3; the liquid outlet is fixed with an output tube (not shown in the figure), which is led into a receiving container to collect the corresponding product.
[0024] The following is a detailed explanation based on specific cases.
[0025] Example 1
[0026] This embodiment provides a method for preparing giant liposomes without surfactant dehumidification, and the steps are as follows: 1) Preparation of continuous phase fluid: At normal pressure and room temperature, add 2 g of polyvinyl alcohol to 20 mL of deionized water, stir evenly to form a continuous phase fluid, and filter it for later use.
[0027] 2) Preparation of the first dispersed phase fluid: At normal pressure and room temperature, take 200 μL of chloroform solution of 50 mg / mL phospholipid into a glass bottle, blow dry the chloroform with nitrogen to form a phospholipid membrane. Then add 2 mL of triolein, sonicate at 50°C for 1 h to dissolve the phospholipids, and form the first dispersed phase fluid.
[0028] 3) Preparation of the second dispersed phase fluid: Add 0.4 g polyvinyl alcohol and 1.6 g polyethylene glycol to 20 mL deionized water at normal pressure and room temperature, stir evenly to form the second dispersed phase fluid, and filter for later use.
[0029] 4) The second dispersed phase fluid prepared in step 3) is used as the inner phase (IA), the first dispersed phase fluid prepared in step 2) is used as the intermediate phase (LO), and the continuous phase fluid prepared in step 1) is used as the outer phase (OA) and injected into different liquid inlets of the two-stage droplet generator of the microfluidic device through a syringe connected to a syringe pump to form water-in-oil-in-water double emulsion droplets. The inner phase flow rate Q W1 The intermediate phase flow rate Q is 80 μL / h. O is 200 μL / h, and the external phase flow rate Q W2 2000μL / h.
[0030] 5) The sample is placed at the liquid outlet of the microfluidic device in step 4), where the double emulsion will spontaneously undergo a dewetting process (see Figure 3 ), a clear separation boundary appears at 60s, dehumidification is completed at 102s, and the following is formed: Figure 2 The giant liposomes shown. The obtained liposomes have clear outlines and their diameters are basically kept above 50 μm.
[0031] Example 2
[0032] The configuration of this embodiment is the same as that of embodiment 1, except that: In step 2), 2 μg of rhodamine fluorescently labeled phospholipids were also added to triolein.
[0033] In step 3), 0.02 mg of calcein was also added to the second dispersed phase fluid.
[0034] The liposome solution was dropped onto the coverslip and observed using a fluorescence microscope after being excited by lasers at wavelengths of 488 nm and 561 nm. Figure 4 As shown, a clear red ring appears in the field of view, indicating that the outer layer of the vesicle is a phospholipid membrane, and the interior continues to emit green fluorescence, indicating that the vesicle is intact and the contents have not leaked.
[0035] Example 3
[0036] This embodiment provides a method for preparing giant liposomes without surfactant dehumidification, and the steps are as follows: 1) Preparation of continuous phase fluid: At normal pressure and room temperature, add 2 g of polyvinyl alcohol to 20 mL of deionized water, stir evenly to form a continuous phase fluid, and filter it for later use.
[0037] 2) Preparation of the first dispersed phase fluid: At normal pressure and room temperature, take 200 μL of chloroform solution of 50 mg / mL phospholipid into a glass bottle, blow dry the chloroform with nitrogen to form a phospholipid membrane. Then add 2 mL of triolein, sonicate at 50°C for 1 h to dissolve the phospholipids, and form the first dispersed phase fluid.
[0038] 3) Preparation of the second dispersed phase fluid: Add 2 g of polyethylene glycol to 20 mL of deionized water at normal pressure and room temperature, stir evenly to form the second dispersed phase fluid, and filter for later use.
[0039] 4) The second dispersed phase fluid prepared in step 3) is used as the inner phase (IA), the first dispersed phase fluid prepared in step 2) is used as the intermediate phase (LO), and the continuous phase fluid prepared in step 1) is used as the outer phase (OA) and injected into different liquid inlets of the two-stage droplet generator of the microfluidic device through a syringe connected to a syringe pump to form water-in-oil-in-water double emulsion droplets. The inner phase flow rate Q W1 The intermediate phase flow rate Q is 80 μL / h. O is 200 μL / h, and the external phase flow rate Q W2 It is 2300μL / h.
[0040] 5) The sample is connected to the liquid outlet of the microfluidic device in step 4), wherein the double emulsion will spontaneously undergo a dewetting process and form giant vesicles, and the diameter of the giant vesicles is uniform.
[0041] Compared with Example 1, this case uses polyethylene glycol to form the second dispersed phase fluid, the continuous phase and the first dispersed phase fluid remain unchanged, and the outward flow rate is increased, and the same quality liposomes can also be achieved.
[0042] Example 4
[0043] This embodiment provides a method for preparing giant liposomes without surfactant dehumidification, and the steps are as follows: 1) Preparation of continuous phase fluid: At normal pressure and room temperature, add 1.4 g sucrose to 20 mL deionized water, stir evenly to form a continuous phase fluid, and filter it for later use.
[0044] 2) Preparation of the first dispersed phase fluid: At normal pressure and room temperature, take 200 μL of chloroform solution of 50 mg / mL phospholipid into a glass bottle, blow dry the chloroform with nitrogen to form a phospholipid membrane. Then add 2 mL of triolein, sonicate at 50°C for 1 h to dissolve the phospholipids, and form the first dispersed phase fluid.
[0045] 3) Preparation of the second dispersed phase fluid: Add 0.7 g of glucose to 20 mL of deionized water at normal pressure and room temperature, stir evenly to form the second dispersed phase fluid, and filter for later use.
[0046] 4) The second dispersed phase fluid prepared in step 3) is used as the inner phase (IA), the first dispersed phase fluid prepared in step 2) is used as the intermediate phase (LO), and the continuous phase fluid prepared in step 1) is used as the outer phase (OA) and injected into different liquid inlets of the two-stage droplet generator of the microfluidic device through a syringe connected to a syringe pump to form water-in-oil-in-water double emulsion droplets. The inner phase flow rate Q W1is 100 μL / h, and the intermediate phase flow rate Q O is 200 μL / h, and the external phase flow rate Q W2 4000μL / h.
[0047] 5) The sample is collected at the liquid outlet of the microfluidic device in step 4), wherein the double emulsion will spontaneously undergo a dewetting process to obtain liposomes, and the diameter of the giant liposomes is uniform.
[0048] Compared with Example 1, when the same first dispersed phase fluid is used, glucose is used instead of polyvinyl alcohol and polyethylene glycol to form the second dispersed phase fluid, and sucrose is used instead of polyvinyl alcohol to form the continuous phase, and a higher flow rate is used, the same liposomes can be obtained.
[0049] The above description of the embodiments is to facilitate the understanding and use of the present invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments. Improvements and modifications made by those skilled in the art based on the principles of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.
Claims
1. A method for preparing giant liposomes without surfactant dehumidification, characterized in that: Phospholipids are dissolved in triolein to form a first dispersed phase fluid, which is matched with corresponding continuous phase and second dispersed phase fluids. The continuous phase is used as the outer phase, the first dispersed phase fluid is used as the middle phase, and the second dispersed phase fluid is used as the inner phase. The three are respectively injected into a microfluidic device, and the formed double emulsion is spontaneously dehumidified to obtain giant liposomes with an outer diameter of 30 to 150 μm.
2. The method for preparing giant liposomes without surfactant dehumidification according to claim 1, characterized in that: The amount of phospholipids in each mL of triolein is 0.001~0.02g.
3. The method for preparing giant vesicles without surfactant dehumidification according to claim 1, characterized in that: The preparation method of the first dispersed phase fluid is: at normal pressure and room temperature, a chloroform solution of phospholipids is blown dry with nitrogen to form a phospholipid film, triolein is added, and the phospholipids are dissolved by ultrasound to form the first dispersed phase fluid.
4. The method for preparing giant liposomes without surfactant dehumidification according to claim 1, characterized in that: The continuous phase is a polyvinyl alcohol aqueous solution or a sucrose aqueous solution.
5. The method for preparing giant liposomes without surfactant dehumidification according to claim 4, characterized in that: The polyvinyl alcohol aqueous solution is formed by dissolving polyvinyl alcohol in deionized water, and the mass ratio of polyvinyl alcohol to water is 0.01-0.3:1; the sucrose aqueous solution is formed by mixing sucrose and deionized water, and the mass ratio of sucrose to deionized water is 0.05-0.1:
1.
6. The method for preparing giant liposomes without surfactant dehumidification according to claim 1, characterized in that: The second dispersed phase is a polyethylene glycol aqueous solution, a polyvinyl alcohol and polyethylene glycol aqueous solution, or a glucose aqueous solution.
7. The method for preparing giant vesicles without surfactant dehumidification according to claim 6, characterized in that: In the aqueous solution of polyvinyl alcohol and polyethylene glycol, the mass ratio of polyvinyl alcohol to deionized water is 0.01-0.1:1, and the mass ratio of polyethylene glycol to deionized water is 0.01-0.3:1; in the aqueous solution of polyethylene glycol, the mixing mass ratio of polyethylene glycol to deionized water is 0.01-0.3:1; in the aqueous solution of glucose, the mass ratio of glucose to deionized water is 0.01-0.1:
1.
8. The method for preparing giant liposomes without surfactant dehumidification according to claim 1, characterized in that: In the microfluidic device, the flow rate Q of the first dispersed phase fluid is O The flow rate of the second dispersed phase fluid Q is 50~1500μL / h. W1 The flow rate of the continuous phase fluid is 50 to 1000 μL / h. W2 1000~5000μL / h.
9. The method for preparing giant liposomes without surfactant dehumidification according to claim 1, characterized in that: The microfluidic device is a PDMS microfluidic device, with three liquid inlets, three corresponding syringes fixed thereto, and one liquid outlet.
10. A method for preparing giant vesicles without surfactant dehumidification according to any one of claims 1 to 9, characterized in that: The lipid-containing first dispersed phase fluid shears the second dispersed phase fluid to form an oil-in-water single emulsion, and the single emulsion is further sheared by the external continuous phase fluid to form a double emulsion, and the double emulsion spontaneously dewets to form liposomes.
